Kirin (OTCMKTS:KNBWY) Shares Gap Down – Here’s Why

Kirin Holdings Co. (OTCMKTS:KNBWY)’s stock price gapped down prior to trading on Friday . The stock had previously closed at $18.32, but opened at $17.35. Kirin shares last traded at $17.35, with a volume of 167 shares changing hands.

Analysts Set New Price Targets

Separately, Zacks Research downgraded shares of Kirin from a “hold” rating to a “strong sell” rating in a report on Monday, August 31st. One analyst has rated the stock with a Sell rating, According to data from MarketBeat.com, the company currently has a consensus rating of “Sell”.

Kirin Stock Performance

The company has a debt-to-equity ratio of 0.48, a current ratio of 1.48 and a quick ratio of 1.01. The stock has a market cap of $14.72 billion, a P/E ratio of 11.57 and a beta of -0.01. The stock has a 50-day simple moving average of $18.59 and a 200-day simple moving average of $17.29.

Kirin (OTCMKTS:KNBWY) last posted its earnings results on Friday, August 7th. The company reported $0.58 EPS for the quarter, topping analysts’ consensus estimates of $0.42 by $0.16. Kirin had a net margin of 7.79% and a return on equity of 12.22%. The firm had revenue of $4.08 billion during the quarter, compared to analysts’ expectations of $3.87 billion. Research analysts forecast that Kirin Holdings Co. will post 1.34 earnings per share for the current year.

About Kirin

Kirin Holdings Company, Limited is a Japan-based company with businesses spanning alcoholic and nonalcoholic beverages, pharmaceuticals and health science. Its beverage operations include beer, wine, spirits, soft drinks, bottled water and other consumer products marketed under brands such as Kirin, Ichiban Shibori and Afternoon Tea.

The company’s pharmaceutical business is conducted primarily through Kyowa Kirin, which researches, develops and commercializes prescription medicines, including treatments in areas such as oncology, immunology and nephrology.